 Glucose Tolerance Test
"Glucose Tolerance Test" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg).
| Descriptor ID |
D005951
|
| MeSH Number(s) |
E01.370.225.124.100.355 E01.370.374.355 E05.200.124.100.355
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glucose Tolerance Test".
Below are MeSH descriptors whose meaning is more specific than "Glucose Tolerance Test".
This graph shows the total number of publications written about "Glucose Tolerance Test" by people in this website by year, and whether "Glucose Tolerance Test" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 | | 1996 | 0 | 3 | 3 | | 1997 | 0 | 2 | 2 | | 1998 | 0 | 2 | 2 | | 1999 | 0 | 4 | 4 | | 2000 | 0 | 3 | 3 | | 2001 | 0 | 3 | 3 | | 2002 | 0 | 3 | 3 | | 2003 | 0 | 2 | 2 | | 2004 | 0 | 4 | 4 | | 2005 | 0 | 6 | 6 | | 2006 | 0 | 2 | 2 | | 2007 | 0 | 6 | 6 | | 2008 | 2 | 9 | 11 | | 2009 | 0 | 12 | 12 | | 2010 | 1 | 6 | 7 | | 2011 | 0 | 6 | 6 | | 2012 | 0 | 11 | 11 | | 2013 | 1 | 6 | 7 | | 2014 | 0 | 14 | 14 | | 2015 | 0 | 9 | 9 | | 2016 | 1 | 13 | 14 | | 2017 | 0 | 12 | 12 | | 2018 | 0 | 16 | 16 | | 2019 | 0 | 13 | 13 | | 2020 | 1 | 11 | 12 | | 2021 | 1 | 14 | 15 | | 2022 | 1 | 5 | 6 | | 2023 | 0 | 6 | 6 | | 2024 | 1 | 3 | 4 | | 2025 | 0 | 6 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Glucose Tolerance Test" by people in Profiles.
-
Durieu I, Clements B, Fabrizzi B, Mall MA, McKone E, Ramsey B, Tullis E, Taylor-Cousar JL, van der Meer R, Bachman E, Chin A, Conner S, Jennings M, Weinstock T, Colombo C, Robinson P. Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial. Am J Respir Crit Care Med. 2025 Oct; 211(10):1926-1934.
-
Chan CL, Shirley Bezerra M, Stefanovski D, Gallop RJ, Walega R, Donaldson SH, Frederick CA, Freedman SD, Gelfond D, Hoffman LR, Narkewicz MR, Rowe SM, Sagel SD, Schwarzenberg SJ, Solomon GM, Stalvey MS, Kelly A. Glycemia and Insulin Secretion in Cystic Fibrosis 2 Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO. J Clin Endocrinol Metab. 2025 Aug 07; 110(9):2674-2684.
-
Harrall KK, Glueck DH, Lange LA, Litkowski EM, Vanderlinden LA, Konigsberg IR, Cree MG, Perng W, Dabelea D. GLP-1R Gene Polymorphisms and Metabolic Traits During Childhood and Adolescence: The EPOCH Study. J Clin Endocrinol Metab. 2025 Aug 07; 110(9):e3031-e3040.
-
Utzschneider KM, Tripputi M, Butera NM, Mari A, Rosin SP, Banerji MA, Bergenstal RM, Brown N, Carlson AL, DeFronzo RA, Gramzinski MR, Harindhanavudhi T, Kozedub A, Sivitz WI, Steffes MW, Balasubramanyam A, Rasouli N. Differential Treatment Effects on ß-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care. 2025 Apr 01; 48(4):623-631.
-
Triolo TM, Parikh HM, Tosur M, Ferrat LA, You L, Gottlieb PA, Oram RA, Onengut-Gumuscu S, Krischer JP, Rich SS, Steck AK, Redondo MJ. Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):e1046-e1050.
-
Zhao J, Massoudian SD, Stray-Gundersen S, Wojan F, Lalande S. Short bouts of hypoxia improve insulin sensitivity in adults with type 2 diabetes. J Appl Physiol (1985). 2025 Apr 01; 138(4):873-880.
-
Bonet J, Weiss R, Galderisi A, Dalla Man C, Caprio S, Santoro N. Adipose tissue insulin resistance in children and adolescents: linking glucose and free fatty acid metabolism to hepatic injury markers. Am J Physiol Endocrinol Metab. 2024 Dec 01; 327(6):E723-E728.
-
Triolo TM, Jacobsen LM, Cuthbertson D, Sims EK, Ismail HM, Redondo MJ, Lundgren M, DiMeglio LA, Gottlieb PA, Atkinson MA, Krischer JP, Schatz DA, Sosenko JM. Effect of Oral Insulin on Early Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes. Pediatr Diabetes. 2024; 2024:8343868.
-
Shapiro ALB, Tjaden AH, Edelstein SL, Kahn SE, Srikanthan P, Knowler WC, Venditti EM, Golden SH, Carmichael O, Luchsinger JA. The association of insulin responses and insulin sensitivity with cognition in adults with pre-diabetes: The Diabetes Prevention Program Outcomes Study. J Diabetes Complications. 2024 06; 38(6):108764.
-
Abushamat LA, Schauer IE, Low Wang CC, Mitchell S, Herlache L, Bridenstine M, Durbin R, Snell-Bergeon JK, Regensteiner JG, Reusch JE. Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study. J Investig Med. 2024 03; 72(3):294-304.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|